Dudediligence.

Neuphoria Therapeutics Inc

NEUPNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

5.41M

on 2026-09-17, from 1.63M on 2024-12-31 10-K ↗

Counts before 2024-12-31 are left out: the count went from 3.12B on 2024-09-30 to 1.63M on 2024-12-31, a change no split on file explains.

2M4MDec2024Mar2025JunSepDecMar2026JunSep

Newest

S-3 of 2025-01-24. Not read yet. S-3 ↗

$20.0M

Agreement of 2025-11-14. The amount sold under this agreement is not stated apart in the 10-K. 424B5 ↗

Warrants

1.05M

Priced warrants: 1.05M at $11.88, 2026-06-30. 10-K ↗

Cash

6.4 quarters

$19.9M on 2026-06-30 ÷ $3.1M a quarter of operating cash used, the average of four quarters. 10-K ↗

Raised: 9 of its filings are not read yet.